AngioDynamics Inc Earnings: Beat on EPS with $0.02 vs -$0.11 Expected

AngioDynamics Inc (ANGO) delivered a significant earnings beat for the quarter ended April 2, 2026, reporting earnings per share of $0.02 versus analyst estimates of -$0.11, representing a positive surprise of 117.83%.

The medical device company’s actual EPS of $0.02 marked a substantial outperformance against the consensus estimate of -$0.11, with the 117.83% surprise indicating the company exceeded expectations by $0.13 per share.

Revenue came in at $78.42 million compared to estimates of $78.30 million, delivering a modest beat with a surprise of 0.15%. The revenue figure of $78,423,000 exceeded analyst projections by approximately $121,000.

The quarter’s results showed AngioDynamics achieving profitability with the $0.02 EPS versus the anticipated loss of $0.11 per share. Revenue performance of $78.42 million represented steady execution against the $78.30 million consensus target.

This article is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results.